Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
5.66
+0.47 (9.06%)
At close: Aug 20, 2026

SHA:688373 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7143,9603,2374,2795,805-
Market Cap Growth
-29.45%22.34%-24.35%-26.30%--
Enterprise Value
3,6643,8412,8003,4434,701-
Last Close Price
5.666.044.946.538.86-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
24.6627.9324.8547.13120.42-
PB Ratio
20.4119.277.375.134.78-
P/TBV Ratio
20.5119.367.405.144.79-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
24.3327.0921.5037.9397.53-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.041.850.690.270.190.37
Net Debt / Equity Ratio
-0.27-0.35-0.66-0.88-0.86-0.71
Net Debt / EBITDA Ratio
0.250.290.671.674.061.16
Net Debt / FCF Ratio
0.290.340.652.174.121.53
Asset Turnover
0.200.180.130.070.050.01
Inventory Turnover
0.470.420.500.560.540.09
Quick Ratio
1.672.273.057.1411.135.03
Current Ratio
2.072.773.537.7211.915.41
Return on Equity (ROE)
-71.14%-74.98%-69.24%-41.12%-26.66%-42.75%
Return on Assets (ROA)
-16.77%-19.88%-27.18%-20.63%-15.00%-25.55%
Return on Capital Employed (ROCE)
-52.70%-51.40%-68.90%-42.60%-18.60%-48.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.42%-6.10%-13.62%-9.84%-3.79%-
FCF Yield
-4.70%-5.32%-13.84%-7.87%-4.34%-
Buyback Yield / Dilution
1.32%0.73%-0.33%-13.09%-10.17%-106.16%